A Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of KM-819 in Healthy Older Adults and Participants With Parkinson's Disease
The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's disease.
The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in healthy older adults and participants with Parkinson's disease.
100 项与 Fascinate Therapeutics , Inc. 相关的临床结果
0 项与 Fascinate Therapeutics , Inc. 相关的专利(医药)
100 项与 Fascinate Therapeutics , Inc. 相关的药物交易
100 项与 Fascinate Therapeutics , Inc. 相关的转化医学